Cost-effectiveness analysis of allopurinol versus febuxostat in chronic gout patients: a U.S. payer perspective. [electronic resource]
Producer: 20151009Description: 165-75 p. digitalISSN:- 2376-1032
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.